These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 25030535)
21. Serum amyloid A is independently related to apolipoprotein A-I but not to HDL-cholesterol in patients with angina pectoris. Korita I; Bulo A; Langlois MR; Verhoye E; Blaton V Clin Biochem; 2013 Nov; 46(16-17):1660-3. PubMed ID: 23994331 [TBL] [Abstract][Full Text] [Related]
22. Cholesteryl ester transfer protein inhibition, high-density lipoprotein raising, and progression of coronary atherosclerosis: insights from ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation). Nicholls SJ; Tuzcu EM; Brennan DM; Tardif JC; Nissen SE Circulation; 2008 Dec; 118(24):2506-14. PubMed ID: 19029466 [TBL] [Abstract][Full Text] [Related]
23. Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis. Boekholdt SM; Arsenault BJ; Hovingh GK; Mora S; Pedersen TR; Larosa JC; Welch KM; Amarenco P; Demicco DA; Tonkin AM; Sullivan DR; Kirby A; Colhoun HM; Hitman GA; Betteridge DJ; Durrington PN; Clearfield MB; Downs JR; Gotto AM; Ridker PM; Kastelein JJ Circulation; 2013 Oct; 128(14):1504-12. PubMed ID: 23965489 [TBL] [Abstract][Full Text] [Related]
24. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio. Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP; J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584 [TBL] [Abstract][Full Text] [Related]
25. HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease. Kuchta A; Strzelecki A; Ćwiklińska A; Gruchała M; Zdrojewski Z; Kortas-Stempak B; Wieczorek E; Gliwińska A; Dąbkowski K; Jankowski M J Cardiol; 2017 Mar; 69(3):523-528. PubMed ID: 27169356 [TBL] [Abstract][Full Text] [Related]
27. Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study. Räber L; Taniwaki M; Zaugg S; Kelbæk H; Roffi M; Holmvang L; Noble S; Pedrazzini G; Moschovitis A; Lüscher TF; Matter CM; Serruys PW; Jüni P; Garcia-Garcia HM; Windecker S; Eur Heart J; 2015 Feb; 36(8):490-500. PubMed ID: 25182248 [TBL] [Abstract][Full Text] [Related]
28. Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: the COMPACT-CAD study. Kurogi K; Sugiyama S; Sakamoto K; Tayama S; Nakamura S; Biwa T; Matsui K; Ogawa H; J Cardiol; 2013 Aug; 62(2):87-94. PubMed ID: 23672789 [TBL] [Abstract][Full Text] [Related]
29. Implications of Total to High-Density Lipoprotein Cholesterol Ratio Discordance With Alternative Lipid Parameters for Coronary Atheroma Progression and Cardiovascular Events. Elshazly MB; Nicholls SJ; Nissen SE; St John J; Martin SS; Jones SR; Quispe R; Stegman B; Kapadia SR; Tuzcu EM; Puri R Am J Cardiol; 2016 Sep; 118(5):647-55. PubMed ID: 27392507 [TBL] [Abstract][Full Text] [Related]
30. Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial. Nicholls SJ; Puri R; Ballantyne CM; Jukema JW; Kastelein JJP; Koenig W; Wright RS; Kallend D; Wijngaard P; Borgman M; Wolski K; Nissen SE JAMA Cardiol; 2018 Sep; 3(9):806-814. PubMed ID: 30046837 [TBL] [Abstract][Full Text] [Related]
31. High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies. van der Steeg WA; Holme I; Boekholdt SM; Larsen ML; Lindahl C; Stroes ES; Tikkanen MJ; Wareham NJ; Faergeman O; Olsson AG; Pedersen TR; Khaw KT; Kastelein JJ J Am Coll Cardiol; 2008 Feb; 51(6):634-42. PubMed ID: 18261682 [TBL] [Abstract][Full Text] [Related]
32. ApoA-I induction as a potential cardioprotective strategy: rationale for the SUSTAIN and ASSURE studies. Nicholls SJ; Gordon A; Johannson J; Ballantyne CM; Barter PJ; Brewer HB; Kastelein JJ; Wong NC; Borgman MR; Nissen SE Cardiovasc Drugs Ther; 2012 Apr; 26(2):181-7. PubMed ID: 22349989 [TBL] [Abstract][Full Text] [Related]
33. Controlling for apolipoprotein A-I concentrations changes the inverse direction of the relationship between high HDL-C concentration and a measure of pre-clinical atherosclerosis. Sung KC; Wild SH; Byrne CD Atherosclerosis; 2013 Dec; 231(2):181-6. PubMed ID: 24267222 [TBL] [Abstract][Full Text] [Related]
34. The ratio of HDL-C to apoA-I interacts with free triiodothyronine to modulate coronary artery disease risk. Li L; Cai G; Lu W; Li F; Yu L; Xiao J BMC Cardiovasc Disord; 2021 Oct; 21(1):504. PubMed ID: 34666674 [TBL] [Abstract][Full Text] [Related]
35. Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: insights from intravascular ultrasound. Kataoka Y; Shao M; Wolski K; Uno K; Puri R; Murat Tuzcu E; Hazen SL; Nissen SE; Nicholls SJ Atherosclerosis; 2014 Feb; 232(2):377-83. PubMed ID: 24468151 [TBL] [Abstract][Full Text] [Related]
36. Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound. von Birgelen C; Hartmann M; Mintz GS; Baumgart D; Schmermund A; Erbel R Circulation; 2003 Dec; 108(22):2757-62. PubMed ID: 14623804 [TBL] [Abstract][Full Text] [Related]